首页> 外文期刊>Cardiovascular Research >Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart.
【24h】

Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart.

机译:美托洛尔和伊伐布雷定对梗塞后大鼠心脏左心室重构和Ca2 +处理的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

AIMS: beta-Blockers reduce mortality and morbidity in heart failure. Many of their benefits can be explained solely by heart rate reduction (HRR). We aimed to verify whether the beta-blocker, metoprolol, and the pure heart-rate-reducing agent, ivabradine, have the same effects on haemodynamic function, ventricular remodeling, and Ca2+ handling in post-myocardial infarction (MI) heart failure in rat. METHODS AND RESULTS: Metoprolol (250 mg/kg/day) or ivabradine (10 mg/kg/day), offering similar HRR, or no treatment, was started 24 h after an induction of MI or sham surgery in rat. Eight weeks post-MI metoprolol and ivabradine similarly partially prevented deterioration of left ventricular (LV) ejection fraction and reduced post-MI LV wall stress. However, metoprolol partially prevented LV dilation, whereas ivabradine potentiated LV hypertrophy. Metoprolol, but not ivabradine, partially prevented post-MI chronotropic incompetence. Metoprolol markedly, whereas ivabradine mildly, increased the amplitude of the Ca2+ transient in post-MI cardiomyocytes. Ivabradine, but not metoprolol, partially prevented the MI-induced depression of sarcoplasmic reticulum Ca2+-ATPase (SERCA) activity, while metoprolol, but not ivabradine, suppressed Na+/Ca2+ exchanger (NCX) overactivity and normalized Ca2+ sensitivity of ryanodine receptors. CONCLUSION: Although both metoprolol and ivabradine comparably prevented post-MI deterioration of haemodynamic function in the rat, metoprolol had additional potentially beneficial effects; it prevented LV dilation and hypertrophy, chronotropic incompetence, strongly increased contractility of isolated cardiomyocytes, and prevented the potentially proarrhythmic increase in NCX activity. This indicates that pure HRR does not account for effects of beta-blockade in the post-MI setting. Metoprolol and ivabradine similarly improve LV function, although differently affect LV morphology and cellular Ca2+ handling in the post-infarction rat heart.
机译:目的:β受体阻滞剂可降低心力衰竭的死亡率和发病率。它们的许多好处只能通过降低心率(HRR)来解释。我们旨在验证β受体阻滞剂美托洛尔和纯心率降低剂ivabradine对大鼠心肌梗死(MI)心力衰竭的血流动力学功能,心室重构和Ca2 +处理是否具有相同的作用。方法和结果:在大鼠诱发MI或假手术后24小时开始给予美托洛尔(250 mg / kg /天)或伊伐布雷定(10 mg / kg /天),或提供类似的HRR或不给予治疗。 MI后美托洛尔和伊伐布雷定治疗8周后,同样可以部分预防左心室(LV)射血分数的降低,并降低MI后LV壁应力。然而,美托洛尔部分阻止了LV扩张,而伊伐布雷定增强了LV肥大。美托洛尔(但不是伊伐布雷定)部分预防了MI后变时无能。美托洛尔显着而伊伐布雷定温和地增加了MI后心肌细胞中Ca2 +瞬变的幅度。伊伐布雷定而非美托洛尔部分阻止了MI诱导的肌浆网C​​a2 + -ATPase(SERCA)活性的降低,而美托洛尔而非伊伐布雷定抑制了Na + / Ca2 +交换子(NCX)的过度活性并使莱诺碱受体的Ca2 +敏感性标准化。结论:尽管美托洛尔和伊伐布雷定都可预防心肌梗死后大鼠血流动力学功能的下降,但美托洛尔还具有其他潜在的有益作用。它防止了LV扩张和肥大,变时性功能丧失,离体心肌细胞的强烈收缩,并防止了NCX活性潜在的心律失常性增加。这表明纯HRR不能解释MI后环境中β受体阻滞的影响。美托洛尔和伊伐布雷定相似地改善了左室功能,尽管在梗塞后大鼠心脏中对左室形态和细胞Ca2 +处理的影响不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号